The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR Teams with National Bone Health Alliance to Increase Focus on Osteoporosis, Bone Disease

The ACR Teams with National Bone Health Alliance to Increase Focus on Osteoporosis, Bone Disease

February 15, 2017 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF
No single specialty focuses on bone health, and yet bone health in general, and osteoporosis in particular, are among the most common reasons patients are seen in rheumatology practices.

No single specialty focuses on bone health, and yet bone health in general, and osteoporosis in particular, are among the most common reasons patients are seen in rheumatology practices.
Lightspring/shutterstock.com

Bone health in general, and osteoporosis in particular, is among the most common conditions seen in rheumatology practices. The ACR recently joined the National Bone Health Alliance (NBHA) to reach out to other stakeholders.

You Might Also Like
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
  • Romosozumab Improves Bone Mineral Density in Men with Osteoporosis
  • Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease
Explore This Issue
February 2017
Also By This Author
  • New Toolkits Ease Pediatric-to-Adult-Care Transitions for Rheumatology Patients

“In 2004, the Surgeon General of the United States published a report on osteoporosis that discussed in depth the gaps in knowledge exhibited by both healthcare providers and patients,” says David Lee, MPA, executive director of NBHA in Arlington, Va. “It also talked about the need to establish a widespread coalition to bring all of the interested parties together. The NBHA was launched in late 2010 as a public–private partnership geared toward addressing these concerns.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The NBHA comprises 50 nonprofit and corporate members. These include other medical specialty organizations, major pharmaceutical companies with an interest in bone disease, and representatives of various patient advocacy groups. There are also liaisons from five governmental agencies, including the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, the National Aeronautics and Space Administration, and the Centers for Medicare and Medicaid Services.

Rheumatologists in the Bone Health World

Mr. Lee

Mr. Lee

Rheumatologists are front and center in the bone health world,” says Kenneth G. Saag, MD, Jane Knight Lowe Professor of Medicine and Epidemiology at the University of Alabama at Birmingham, the first rheumatologist to serve as president of the National Osteoporosis Foundation and as co-chair of the Alliance’s steering committee. “The vast majority of this specialty has some engagement in osteoporosis and other bone diseases. The NBHA is a forum for groups to get together and talk about advocacy, education and programming.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

One of the major problems the Alliance is trying to address is that there is really no single specialty where bone health is all they do. This spreading out of responsibility can often mean a lack of continuity in research, education and treatment.

“Endocrinology, orthopedics, geriatrics and even family medicine physicians all have a hand in treatment of this disease,” notes Mr. Lee.

Focus on 3 Major Areas

The NBHA is currently focusing on three major topics of interest to the field. The national awareness campaign, 2Million2Many, highlights the 2 million bone breaks that occur in the U.S. every year due to osteoporosis. Created in 2012, the campaign raises public awareness of the connection between bone breaks and osteoporosis. It is based on a call to action for consumers and healthcare professionals alike: “If it’s 50+fracture, request a test.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: AC&R, Advocacy, American College of Rheumatology, Awareness, bone break, bone disease, Education, Fractures, National Bone Health Alliance, OsteoporosisIssue: February 2017

You Might Also Like:
  • Serum Bone Markers CTX, PINP Not Linked with Hip Fracture Risk in Osteoporosis
  • Romosozumab Improves Bone Mineral Density in Men with Osteoporosis
  • Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease
  • Changes in Bone Markers Predict Fracture Reduction with Anti-Resorptive Drug

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)